Skip to main content
. 2015 Mar 25;6(11):8579–8592. doi: 10.18632/oncotarget.3287

Figure 2. Meta-analysis of associations between LINC00472 expression and clinicopathological features of breast cancer.

Figure 2

Summarized odds ratios were estimated using the random-effect model, and the odds ratio in each study was weighted with the variance of probe values (inverse-variance weighted method). A. Lower LINC00472 expression associated with high tumor grade (OR = 2.81; 95% CI: 2.24–3.53), positive lymph node (OR = 1.51; 95% CI: 1.22–1.87), or molecular subtypes of luminal B, Her2 positive and basal-like (OR = 3.80; 95% CI: 2.38–6.07). B. Higher LINC00472 expression associated with ER positive tumors (OR = 0.44; 95% CI: 0.35–0.57), PR positive tumors (OR = 0.44; 95% CI: 0.35–0.55), or Her2 negative tumors (OR = 2.62; 95% CI: 1.76–3.90).